TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Unternehmens-codeTXMD
Name des UnternehmensTherapeuticsMD Inc
IPO-datumJan 31, 2001
Gegründet am2010
CEOMr. Marlan D. Walker, J.D.
Anzahl der mitarbeiter1
WertpapierartOrdinary Share
GeschäftsjahresendeJan 31
Addresse951 Yamato Road, Suite 220
StadtBOCA RATON
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl33431
Telefon15619611900
Websitehttps://www.therapeuticsmd.com/
Unternehmens-codeTXMD
IPO-datumJan 31, 2001
Gegründet am2010
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten